Health Robotics Announces a New Exclusive Partnership for its CytoCare(TM) Robot...

Health Robotics Announces a New Exclusive Partnership for its CytoCare(TM) Robot and a Review of its Customer Adoption and Sales Operations Worldwide Over the Last 12 Months

KING OF PRUSSIA, Pa.--(Business Wire)--
Health Robotics today announced an exclusive agreement with
Can-Med, a leading IV Solution provider and medical device company in
the Republic of Turkey, in order to safely, accurately, and
cost-effectively automate the preparation of life-critical
patient-specific Oncology IV Admixtures with Health Robotics'
CytoCare(TM). With its CytoCare(TM) Robot, Health Robotics has
developed and deployed the world's first and only totally automated
system for safe preparation of patient-specific Oncology IV doses in
Europe, the United States of America, Asia-Pacific, and the Middle
East. While other companies have for years made promises of robotic
automation products in this area and showcased marketing
demonstrations of competing solutions that were supposed to exist as
far back as five years ago, the fact remains that CytoCare(TM) is the
only available solution that currently exists anywhere in the world to
automatically compound and prepare hazardous and non-hazardous
Oncology IV doses, and that has been proven in a "live" hospital
environment.

"CytoCare(TM) constitutes a revolutionary advance for patients and
clinicians' safety. This exclusive partnership with Health Robotics
combines unique state-of-the-art robotics technology with Can-Med's
leading medical devices and IV Admixture services to achieve the
protection, accuracy and sterility that we required for automating
patient-specific IV Admixture preparations. The resulting solution is
the only totally automated system for safe handling and preparation of
hazardous IV Admixtures truly available anywhere in the world," stated
Ramazan Balak, General Manager of Can-Med.

"In this day, age and industry full of false vendor promises, it
was very satisfying to have Health Robotics ship two CytoCare(TM)
units less than one month after we purchased them. We have ordered
another two CytoCare(TM) units for September delivery and an
additional 13 robots over the next six months. This agreement tightly
fits with Can-Med's mission of becoming customers' first choice for
Infusion Therapy and providing world-class technology for our IV
pharmacy operations. We hope that this strategic collaboration with
Health Robotics grows over time in delivering improved patient safety
solutions to our IV medication customer sites in areas beyond oncology
and to continue the integration work we have initiated between
CytoCare(TM) and our industry-leading BD syringes and EVA IV bags
light-protected medical products. We also hope to soon reach an
agreement with Health Robotics on expanding CytoCare(TM) utilization
rights in other countries such as Israel and Iran. Once we saw the
robot in a live operation, effectively and efficiently producing doses
for real patients at Bozen General Hospital, and discussed its proven
features and benefits with both the Chief Pharmacist, Dr. Paluselli,
and the Sterile Compounding Pharmacist, Alicia Tavella, we were
convinced that CytoCare(TM) was both the answer for our current needs
and the gold standard for the future of our company and our
customers," concluded Hilmi Sunay, General Manager of Can-Med's IV
Therapy.

Over the past year Health Robotics has significantly added to its
already impressive leadership position in the sector of IV Admixtures
automation. The company has solidified its partnership with B|Braun in
some European and Asia-Pacific countries; secondly, very positive
dividends are beginning to emerge out of the investments we and our
partners have made with CytoCare(TM) in USA, Middle East and Japan;
and lastly, the company has received an unprecedented positive
response to the announcement of its non-hazardous IV medications
solution IV Station(TM). "We are very pleased to be working with such
serious partners as Can-Med. They join a growing list of health care
providers that have installed CytoCare(TM) since we launched it,"
stated Werner Rainer, CEO of Health Robotics.

"From a customer adoption perspective I would like to share that
in a little more than one year we have installed more IV robots than
all of our competitors have sold in over 10 years of trying, and we
have received purchase orders for over several hundred more robots
than all of our competitors combined. Recently we are very pleased to
see great progress in the hospitals' reception for CytoCare(TM) in new
countries such as Germany, Australia, Japan, Taiwan, France, Belgium,
Czech Republic, Slovakia, and Austria, and also in the United States
with installations at the University of Michigan, Jackson Memorial
Hospital, the University of Pennsylvania, and Brigham and Women's
Hospital. From the perspective of how our customers are deploying
CytoCare(TM), I am also pleased to share that extensive tests with
thousands of IV doses conducted by both the University of Colorado in
Denver and Charing Cross NHS in London have proven in the real-world
environment that CytoCare(TM) features prevent cross-contamination and
deliver sterile and extremely accurate, ready-to-administer Oncology
IV doses," concluded Rainer.

About Health Robotics:

Health Robotics is the global leading supplier in the automation
of life-critical intra-venous patient-specific medication preparation,
compounding, and dispensing, providing health care facilities around
the world with robotics and software automation solutions. The
world-leading solutions CytoCare(TM) and IV Station(TM) have and will
greatly contribute to ease global pharmacies' growing pressures to
improve patient safety through the effective and efficient production
of sterile, accurate, and ready-to-administer IVs, to decrease
life-threatening medication errors and contamination risks, and to
work more efficiently, increase throughput, reduce waste, and contain
spiraling costs.

About Can-Med:

Can-Med is one of the leading IV solution providers in Turkey and
parts of Eastern Europe, Middle East, and Central Asia. The company is
the fastest growing business in Turkey within the fields of Pharmacy,
IV Preparation and Administration, Oncology, Hemo-Dialysis,
Periton-Dialisys, Diagnostic Testing, and Parenteral Nutrition.

Health Robotics
Jack Risenhoover, 940-395-5623

Copyright Business Wire 2008